Related Experiment Videos
Neoplastic transformation induced by a direct perturbation of DNA
Nature
|July 20, 1978
Abstract:
Treatment of Syrian hamster embryo cells with 5-bromodeoxyuridine followed by near ultraviolet irradiation results in neoplastic transformation of these cells. This demonstrates that a direct perturbation of DNA is sufficient to initiate neoplastic transformation.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Agreement Across 10 Artificial Intelligence Models in Assessing Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Whole-Slide Images.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: OlympiAD.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Rare-Variant Studies to Complement Genome-Wide Association Studies.
Annual review of genomics and human genetics·2018
Loss of LRRK2 Protects Against Ox-LDL-Induced Endothelial Oxidative Damage Via NRF2.
Molecular and cellular biology·2026
A Rare t(1;11)(q42;q23) Rearrangement with Trisomy 8 and Trisomy 21 in a Pediatric Acute Myeloid Leukemia Patient with Aberrant CD7 Expression and Jacob Syndrome: Diagnostic Value of Conventional Cytogenetics and Fluorescence in Situ Hybridization in a Rapidly Fatal Case.
Journal of the Association of Genetic Technologists·2026
Targeting Compensatory AKT Activation Overcomes Resistance to AXL Inhibition in Acute Lymphoblastic Leukemia.
Molecular cancer therapeutics·2026
Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.
Clinical pharmacology and therapeutics·2026
Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.
British journal of haematology·2026